PCR is the major breakthrough for the diagnosis of toxoplasmosis, an infection due to the protozoan Toxoplasma gondii. Primarily developed for diagnosis of congenital toxoplasmosis on amniotic fluid, 1 the PCR assays were secondarily used for the diagnosis of toxoplasmosis in allogeneic bone marrow transplant recipients. [2] [3] [4] In these patients, reactivation of latent cysts is thought to be the main mechanism of cerebral or disseminated toxoplasmosis. The detection of T. gondii DNA in blood has highlighted the possibility to anticipate the diagnosis compared with radiological findings and histology. 4, 5 However, the reliability of the PCR tests is crucial to evaluate the prevalence of Toxoplasma reactivation when the detection of circulating DNA is the only clue to its reactivation.
With the aim of preparing an EBMT multicentric prospective study on the prevalence of toxoplasmosis reactivation in SCT patients, we initiated a quality control study with four European laboratories. T. gondii tachyzoites (strain S3, type II, zymodeme 2) were harvested from the peritoneal exudate of Swiss mice intraperitoneally infected 5 days before, washed, counted using a hemocytometer, serially diluted in Toxoplasma seroınegative EDTA blood, from 3 ϫ 10 5 to 3 tachyzoites/ml of blood, and mailed with negative controls. Shipment was made without cooling using a 24-h delivery service. The sending center waited Table 1 Features and results of the PCR assays of the four participating centers. for the acknowledgment of reception by fax before starting its own PCR procedure. Table 1 shows the huge diversity of the techniques used and the results reported. Although the DNA extraction step was different, the four centers used commercial kits and not an in-house technique. The PCR procedures were as follows: one nested PCR 6 and analysis of PCR products in ELISA microplates; one single run PCR 1 and analysis in ELISA microplates; one real-time quantitative PCR assays with hybridization probes (LightCycler technology, Roche Molecular Biochemicals, Meylan, France); 4 and one both a nested PCR 3,7 and a real-time PCR with a hydrolysis probe (TaqMan technology, Applied Biosystems, Courtaboeuf, France). 5 The target DNA was the T. gondii B1 gene for the four laboratories, plus the 18 S rDNA for center 3. However the primers used for the B1 gene were different. 1, [3] [4] [5] [6] No false positive results were observed. The nested PCR alone (center 1) had the lowest sensitivity, although center 3 claimed a higher sensitivity of their nested PCR assay over the TaqMan PCR assay.
To establish a quality control raises several issues concerning the choice of the model. To spike blood with living tachyzoites can be different from the physiopathologic process. Biological samples spiked with DNA and sent frozen on dry ice can be another strategy. 8 Further specific studies focused on the best blood fractions to be tested are needed. The second point is the choice of the reference strain. The RH strain, the strain most used in laboratories, is genetically different from the non-RH strains which are most common in humans. 9 As a consequence, the primers must hybridize with sequences common to all the T. gondii strains. Several recommendations can be suggested according to the results observed and the general use of PCR for diagnosing infectious agents. First, commercial DNA extraction kits should be preferred to in-house DNA extraction processes. Second, nested PCR assays, which are prone to contamination and are not always more sensitive than one-run PCR tests, should be discouraged, in contrast with real-time PCR assays. As there is no need to open the tubes after the amplifications, the risk of contaminating the environment is dramatically decreased, and as a consequence, so is the risk of false positive results. Third, the primer sequences should also be more consensual. A recent study on toxoplasmosis in allogeneic SCT recipients in Europe has shown that most of the centers include PCR as a diagnostic tool. 10 The present study emphasizes the necessity for regular quality controls with reference samples in the context of multicentric studies to obtain reliable and comparative results. 
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